Nabriva Therapeutics plc Quarterly Preferred Stock, Shares Authorized from Q2 2017 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Nabriva Therapeutics plc quarterly Preferred Stock, Shares Authorized history and growth rate from Q2 2017 to Q2 2023.
  • Nabriva Therapeutics plc Preferred Stock, Shares Authorized for the quarter ending June 30, 2023 was 100M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 100M 0 0% Jun 30, 2023 10-Q 2023-10-19
Q1 2023 100M 0 0% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 100M 0 0% Dec 31, 2022 10-Q 2023-10-19
Q3 2022 100M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 100M 0 0% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 100M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 100M 0 0% Dec 31, 2021 10-K 2023-04-17
Q3 2021 100M 0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 100M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 100M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 100M 0 0% Dec 31, 2020 10-K 2022-03-29
Q3 2020 100M 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 100M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 100M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 100M 0 0% Dec 31, 2019 10-K 2021-03-11
Q3 2019 100M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 100M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 100M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 100M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 100M 0 0% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 100M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 100M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 100M Dec 31, 2017 10-K 2018-03-16
Q3 2017 100M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 100M Jun 30, 2017 10-Q 2017-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.